妊娠时血栓的治疗,是一特殊的问题。开始治疗的效应必须针对胎儿和胎盘区域出血的危险。其复发危险性很大,因此,在整个妊娠期、分娩期和产褥期必须进行预防性治疗。妊娠早期必须观察畸形损伤的危险。诊断妊娠时血栓是一种严重情况,治疗对病人具有重要意义。在临床出现明显血栓时,必须无条件的用静脉造影术确诊,但有时为了观察血栓的上界而忽视骨盆显像。治疗通过纤溶系统的活性作用使血栓溶解。用肝素抗凝血治疗,阻止纤维蛋白继续沉淀及血栓形成。消除已形成的血栓,必须通过机体的自身纤溶防御系统。用链激酶、尿激酶或最近采用组织纤维蛋白溶酶原激活剂溶解血栓。所有激活剂通过纤维蛋白溶解系统迅速激活,由前酶纤维蛋白溶酶至活性纤维 Thrombosis during pregnancy, is a special issue. The effect of starting treatment must be directed at the risk of bleeding in the area of ​​the fetus and placenta. The risk of recurrence is high, so prophylactic treatment is mandatory throughout pregnancy, childbirth and the puerperium. Early pregnancy must observe the risk of deformity damage. Diagnosis of thrombosis during pregnancy is a serious condition, the treatment of patients with great significance. In clinical manifestations of obvious thrombosis, the unconditional use of venography must be diagnosed, but sometimes in order to observe the upper bound of thrombosis and ignore pelvic imaging. Treatment thrombolytic activity through the fibrinolytic system. Heparin anticoagulant therapy to prevent fibrin to continue precipitation and thrombosis. Elimination of thrombosis has been formed, must pass the body’s own fibrinolytic defense system. Thrombosis with streptokinase, urokinase or, more recently, tissue plasminogen activator. All activators are rapidly activated by the fibrinolytic system, consisting of the pre-enzyme plasmin to the active fiber